發(fā)布時(shí)間：2018-06-16 00:48

  本文選題：Tum-5基因 + pLXSN��； 參考：《北華大學(xué)》2008年碩士論文

【摘要】：目的:構(gòu)建攜帶人腫瘤抑素基因(Tumstatin)抗血管生成活性片段Tum-5基因的重組逆轉(zhuǎn)錄病毒載體,使用包裝細(xì)胞PA317將其包裝成假病毒顆粒,并用NIH3T3細(xì)胞對(duì)其進(jìn)行檢測(cè)分析。 方法:用Trizol試劑從胎腎組織中提取總RNA,用RT-PCR法擴(kuò)增Tum-5片段,并將擴(kuò)增片段定向克隆到逆轉(zhuǎn)錄病毒質(zhì)粒pLXSN的MCS。將獲得的重組質(zhì)粒利用電穿孔方法轉(zhuǎn)染PA317細(xì)胞,經(jīng)G418篩選陽(yáng)性克隆并擴(kuò)增培養(yǎng),收集其產(chǎn)生的含Tum-5的假病毒顆粒,用NIH3T3檢測(cè)其病毒滴度及安全性。 結(jié)果:用RT-PCR方法獲得了255bp的Tum-5基因序列(含酶切位點(diǎn)),并將其成功的定向克隆到逆轉(zhuǎn)錄病毒質(zhì)粒pLXSN,測(cè)序結(jié)果表明克隆出的基因序列與Gene Bank中所提供的Tum-5基因序列完全一致。RT-PCR證實(shí),轉(zhuǎn)染后的PA317、NIH3T3細(xì)胞中存在人Tum-5特異性片段,病毒滴度為2.05×104cfu/ml,并且沒有對(duì)NIH3T3細(xì)胞造成二次感染。 結(jié)論:成功的構(gòu)建了攜帶人Tum-5基因的逆轉(zhuǎn)錄病毒載體系統(tǒng),并對(duì)其性狀及療效進(jìn)行了相關(guān)檢測(cè),為腫瘤的抗血管生成治療以及血管依賴性疾病的基因治療提供了一種全新的、有效的、安全的外源性基因?qū)�入的途徑�?br/>[Abstract]:Aim: to construct a recombinant retroviral vector carrying the antiangiogenic activity fragment Tum-5 of human tumor endostatin gene (Tumstatin). The recombinant retroviral vector was packaged into pseudoviral particles by packaging cell line PA317 and detected by NIH3T3 cells. Methods: total RNAs were extracted from fetal kidney tissue with Trizol reagent. Tum-5 fragment was amplified by RT-PCR and cloned into MCSs of retrovirus plasmid pLXSN. The obtained recombinant plasmid was transfected into PA317 cells by electroporation. The positive clones were screened by G418 and cultured. The pseudoviral particles containing Tum-5 were collected and the virus titer and safety of PA317 cells were detected by NIH3T3. Results: the Tum-5 gene sequence of 255bp was obtained by RT-PCR, and successfully cloned into retrovirus plasmid pLXSN.The sequencing results showed that the cloned gene sequence was identical with the Tum-5 gene sequence provided by Gene Bank. Completely consistent. RT-PCR confirmed that, There was a human Tum-5 specific fragment in the transfected PA317- NIH3T3 cells, the titer of the virus was 2.05 脳 104 cfur / ml, and no secondary infection was caused to NIH3T3 cells. Conclusion: the retroviral vector system carrying human Tum-5 gene was successfully constructed, and its character and curative effect were detected, which provided a new method for anti-angiogenesis therapy and gene therapy of vascular dependent diseases. An effective, safe approach to exogenous gene transfer.
【學(xué)位授予單位】：北華大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2008
【分類號(hào)】：R346

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 汪軍遠(yuǎn);;血管生成抑制因子及血管生成抑制療法[J];國(guó)外醫(yī)學(xué)情報(bào);2000年01期

2 李黎;內(nèi)源性腫瘤血管生成抑制物的研究進(jìn)展[J];醫(yī)學(xué)研究生學(xué)報(bào);2004年06期

3 王有為;宋玉光;胡火珍;林洪;邢玉芝;陳芬;;增強(qiáng)型綠色熒光蛋白表達(dá)對(duì)鼠C6細(xì)胞生物學(xué)特征影響的研究[J];四川大學(xué)學(xué)報(bào)(自然科學(xué)版);2006年03期

4 劉娜,劉吉勇;基因治療中載體的研究進(jìn)展[J];山東醫(yī)藥;2005年05期

5 王淑靜,劉興漢;腫瘤抑素的研究進(jìn)展[J];生命的化學(xué);2004年02期

6 董菊子;趙勇;高福興;齊心亮;楊迎桂;;電轉(zhuǎn)染效率影響因素的探討[J];生物技術(shù)通訊;2006年05期

7 陳忠平,黃強(qiáng);抗腫瘤血管在腦腫瘤治療中的研究進(jìn)展[J];實(shí)用腫瘤雜志;1999年01期

8 劉志升;李強(qiáng);;肝細(xì)胞肝癌血管形成分子機(jī)制的研究進(jìn)展[J];天津醫(yī)科大學(xué)學(xué)報(bào);2007年03期

9 栗亞;劉興漢;林雪松;馬洪星;張宇雯;李冀宏;劉遠(yuǎn)莉;李丹;;腫瘤抑素相關(guān)肽T42對(duì)人臍靜脈內(nèi)皮細(xì)胞和人胃腺癌細(xì)胞的抑制作用[J];中國(guó)組織工程研究與臨床康復(fù);2007年10期

10 段小軍,楊柳,周躍,唐康來,王東武;熒光蛋白表達(dá)對(duì)小鼠成纖維細(xì)胞系NIH3T3體外增殖能力的影響[J];中華燒傷雜志;2005年05期

，

本文編號(hào)：2024439